TS
Tambali Suvarna
About Tambali Suvarna
Data last updated:
Tambali Suvarna is a Director at Revivewell Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Revivewell Pharmaceuticals Private Limited reported revenue of ₹15.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Revivewell Pharmaceuticals Private Limited U46497TS2023PTC175962 | Director | 11 Aug 2023 | 2023 | ₹15.9 Lakh (FY 2025) | Active |
Board colleagues of Tambali Suvarna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohammed Irfan | 10276049 | Revivewell Pharmaceuticals Private Limited | Director |
| Sri Ramachandra Murthy Kolavennu | 10276050 | Revivewell Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tambali Suvarna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tambali Suvarna
Tambali Suvarna currently holds 1 directorship: Revivewell Pharmaceuticals Private Limited (Director, since 11 Aug 2023, revenue ₹15.9 Lakh (FY 2025)).
Tambali Suvarna was first appointed on 11 Aug 2023 as Director at Revivewell Pharmaceuticals Private Limited.
The current boards of Tambali Suvarna's companies include Mohammed Irfan (Revivewell Pharmaceuticals Private Limited), Sri Ramachandra Murthy Kolavennu (Revivewell Pharmaceuticals Private Limited).